• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Oncology

Characterization of prognostic markers of residual neoplastic disease following hysterectomy

byAikansha ChawlaandAlex Chan
January 4, 2023
in Oncology, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Prognostic markers of residual disease following a loop electrosurgical excision procedure for cervical intraepithelial neoplasia grade 3 include: positive high-risk HPV, positive margin of specimens, and type II or III transformation zone

2. The most indicative markers were HPV-18 positivity and type III transformation zone

Evidence Rating Level: 2 (Good)

Cervical intraepithelial neoplasia 3 (CIN3), associated with human papillomavirus (HPV) infection, is premalignant state of cervical cancer. Loop electrosurgical excision procedure (LEEP) is an office procedure that is used conization treatment of CIN2-3, allowing for deep excision of the transformation zone. There is however a risk of recurrent or residual lesions, even in those who have negative margins of LEEP specimens, with 29-57% of those who had subsequent hysterectomy showing residual disease. Currently, hysterectomy is not recommended to all women with positive margins after LEEP of CIN 3, and recurrent disease is still found in those with negative margins. Identifying factors that can predict residual lesions may help guide treatment, including clearer indications for hysterectomy. This retrospective study involved 421 patients who had histologically confirmed CIN 3, who then had LEEP and subsequent hysterectomy within 6 months. 44.18% of hysterectomy specimens showed residual disease. Predictive markers in the specimens included positive endocervical curettage (ECC), positive margins, high risk HPV infection and type II or III transformation zoon. HPV-18 positivity and type III transformation zone were most predictive (OR, 7.13; 95% CI, 3.49 to 14.56; p < 0.001 and OR, 6.37; 95% CI, 2.91 to 13.94; p < 0.001 respectively).  Currently, hysterectomy is not recommended to all women with positive margins after LEEP of CIN 3, and recurrent disease is still found in those with negative margins. The retrospective design and limited population size are limitations to this study, as well as duration of HPV infection was not assessed.  However, this study shows that certain markers such as positive high-risk HPV, positive margin of specimens, and type II or III transformation zone are reliable markers of residual disease. Future studies are needed to continue to guide treatment of CIN3 lesions to reduce rates of recurrent and residual disease. 

Click to read the study in BMC Pregnancy and Childbirth

Image: PD

RELATED REPORTS

Vaccinations may be associated with small but temporary changes in menstrual cycle length

Ivonescimab improves survival in advanced non-small cell lung cancer

Sotorasib plus panitumumab may be a promising treatment option for colorectal cancer

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: gynecologyhysterectomyoncology
Previous Post

Vaccines for Zaire Ebola virus disease are safe and generate an immune response

Next Post

Wellness Check: Spirituality

RelatedReports

Medical vaccine exemptions increase after elimination of nonmedical exemptions
Infectious Disease

Vaccinations may be associated with small but temporary changes in menstrual cycle length

May 7, 2025
Lessons from real-world implementation of lung cancer screening
Chronic Disease

Ivonescimab improves survival in advanced non-small cell lung cancer

April 30, 2025
Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs
Gastroenterology

Sotorasib plus panitumumab may be a promising treatment option for colorectal cancer

April 16, 2025
No difference in PET-CT surveillance versus planned neck dissection in advanced head and neck cancer
Cardiology

Genetic, clinical, lifestyle and sociodemographic risk factors for head and neck cancer:

April 13, 2025
Next Post
Early palliative care may improve survival in advanced cancer

Wellness Check: Spirituality

2 Minute Medicine Rewind October 14, 2019

Haloperidol does not improve outcomes at 90 days in ICU patients with delirium

#VisualAbstract: Prophylactic methylprednisolone for cardiac surgery in infants does not improve post-operative outcomes

#VisualAbstract: Prophylactic methylprednisolone for cardiac surgery in infants does not improve post-operative outcomes

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Endothelial Activation and Stress Index as a predictor of mortality in patients with atrial fibrillation
  • No difference between pharmacologic treatments in age-related macular degeneration risk reduction
  • Vaccinations may be associated with small but temporary changes in menstrual cycle length
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.